Treatment with IRLAB Therapeutics‘ small molecule IRL752 is safe and well-tolerated by Parkinson’s disease patients with dementia,…
Inês Martins, PhD
Inês holds a PhD in biomedical sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied cell and molecular biology and worked as a research fellow at multiple institutes. In addition to several college awards, Inês won the Pfizer Basic Research Award in 2012 for a research paper. She also has a graduate degree in data science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Inês Martins, PhD
The Goalkeeper Game, a video game in which people assume the role of a goalkeeper in a soccer penalty…
Researchers at the University of Florida have developed a non-invasive way of following disease progression in Parkinson’s, and its related conditions, that uses…
Using a laboratory model of Parkinson’s disease, researchers have shown how abnormal α-synuclein aggregates gradually spread from an area involved in…
Diseases such as Alzheimer’s, Parkinson’s, and Huntington’s are associated with the formation of large protein aggregates that disrupt a variety of cellular functions.
Studies of the fruit fly, or Drosophila melanogaster, have shown that a protein called clueless, or clu, is associated with the…
A pilot study found that a nasal spray may be a promising and quickly effective way of delivering glutathione (GSH), and of increasing GSH levels…
UCLA Researchers Shed Light on Molecular Mechanisms of Pesticide-Associated Parkinson’s Disease
Exposure to the commonly used pesticide ziram may be linked to Parkinson’s disease development by inducing α-synuclein expression and damages to…
A specific mutation commonly found in Parkinson’s patients has been shown to enhance the expression of α-synuclein (SNCA), a key gene involved in…
Suppressing Brain Immune Responses of Parkinson’s Patients Gives Promising Therapeutic Approach
Inhibitors of the JAK/STAT pathway may provide potential for treating patients with neurodegenerative diseases, particularly Parkinson’s, by reducing the degenerative inflammation…